nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advancements in Understanding Immunogenicity of Biotherapeutics in the Intraocular Space
|
Wakshull, Eric |
|
2017 |
19 |
6 |
p. 1656-1668 |
artikel |
2 |
A Flavonoid Glycoside Compound from Murraya paniculata (L.) Interrupts Metastatic Characteristics of A549 Cells by Regulating STAT3/NF-κB/COX-2 and EGFR Signaling Pathways
|
Shi, Qing |
|
2017 |
19 |
6 |
p. 1779-1790 |
artikel |
3 |
Alternative Splicing: Expanding Diversity in Major ABC and SLC Drug Transporters
|
Park, Ji Eun |
|
2017 |
19 |
6 |
p. 1643-1655 |
artikel |
4 |
Approaches for Establishing Clinically Relevant Dissolution Specifications for Immediate Release Solid Oral Dosage Forms
|
Hermans, Andre |
|
2017 |
19 |
6 |
p. 1537-1549 |
artikel |
5 |
Blood–Brain Barrier Driven Pharmacoresistance in Amyotrophic Lateral Sclerosis and Challenges for Effective Drug Therapies
|
Mohamed, Loqman A. |
|
2017 |
19 |
6 |
p. 1600-1614 |
artikel |
6 |
Characterization of Apolipoprotein C3 (Apo C3) LNA/DNA Impurities and Degradation Products by LC-MS/MS
|
Friese, Olga V. |
|
2017 |
19 |
6 |
p. 1735-1744 |
artikel |
7 |
Comparison of NMR and Dynamic Light Scattering for Measuring Diffusion Coefficients of Formulated Insulin: Implications for Particle Size Distribution Measurements in Drug Products
|
Patil, Sharadrao M. |
|
2017 |
19 |
6 |
p. 1760-1766 |
artikel |
8 |
Determination of Critical Quality Attributes for a Biotherapeutic in the QbD Paradigm: GCSF as a Case Study
|
Singh, Sumit K. |
|
2017 |
19 |
6 |
p. 1826-1841 |
artikel |
9 |
Development of an Enantioselective and Biomarker-Informed Translational Population Pharmacokinetic/Pharmacodynamic Model for Etodolac
|
Miranda Silva, Carolina de |
|
2017 |
19 |
6 |
p. 1814-1825 |
artikel |
10 |
Development of a Translational Physiologically Based Pharmacokinetic Model for Antibody-Drug Conjugates: a Case Study with T-DM1
|
Khot, Antari |
|
2017 |
19 |
6 |
p. 1715-1734 |
artikel |
11 |
Dibenzoylmethane Protects Against CCl4-Induced Acute Liver Injury by Activating Nrf2 via JNK, AMPK, and Calcium Signaling
|
Cao, Mingnan |
|
2017 |
19 |
6 |
p. 1703-1714 |
artikel |
12 |
Drug Target Interference in Immunogenicity Assays: Recommendations and Mitigation Strategies
|
Zhong, Zhandong Don |
|
2017 |
19 |
6 |
p. 1564-1575 |
artikel |
13 |
Early to Long-Term Alterations of CNS Barriers After Traumatic Brain Injury: Considerations for Drug Development
|
Rodriguez-Grande, Beatriz |
|
2017 |
19 |
6 |
p. 1615-1625 |
artikel |
14 |
Exosomes for the Enhanced Tissue Bioavailability and Efficacy of Curcumin
|
Aqil, Farrukh |
|
2017 |
19 |
6 |
p. 1691-1702 |
artikel |
15 |
How Close Are We to Profiling Immunogenicity Risk Using In Silico Algorithms and In Vitro Methods?: an Industry Perspective
|
Gokemeijer, Jochem |
|
2017 |
19 |
6 |
p. 1587-1592 |
artikel |
16 |
Investigating Oral Absorption of Carbamazepine in Pediatric Populations
|
Kohlmann, Philip |
|
2017 |
19 |
6 |
p. 1864-1877 |
artikel |
17 |
Investigation of the Influence of Protein-Losing Enteropathy on Monoclonal Antibody Pharmacokinetics in Mice
|
Yang, Yujie |
|
2017 |
19 |
6 |
p. 1791-1803 |
artikel |
18 |
In vitro Approaches to Support Bioequivalence and Substitutability of Generic Proton Pump Inhibitors via Nasogastric Tube Administration
|
Ren, Ping |
|
2017 |
19 |
6 |
p. 1593-1599 |
artikel |
19 |
Mechanistic Fluid Transport Model to Estimate Gastrointestinal Fluid Volume and Its Dynamic Change Over Time
|
Yu, Alex |
|
2017 |
19 |
6 |
p. 1682-1690 |
artikel |
20 |
Nanotechnology as a Delivery Tool for Precision Cancer Therapies
|
Sharma, Bhawna |
|
2017 |
19 |
6 |
p. 1632-1642 |
artikel |
21 |
New Botanical Anxiolytics for Use in Companion Animals and Humans
|
Liu, Rui |
|
2017 |
19 |
6 |
p. 1626-1631 |
artikel |
22 |
Pharmacokinetics of Mephedrone and Its Metabolites in Human by LC-MS/MS
|
Olesti, Eulàlia |
|
2017 |
19 |
6 |
p. 1767-1778 |
artikel |
23 |
Physiologically Based Pharmacokinetic Modeling of Transporter-Mediated Hepatic Clearance and Liver Partitioning of OATP and OCT Substrates in Cynomolgus Monkeys
|
Morse, Bridget L. |
|
2017 |
19 |
6 |
p. 1878-1889 |
artikel |
24 |
Population Pharmacokinetic and Pharmacodynamic Modeling of Artemisinin Resistance in Southeast Asia
|
Lohy Das, Jesmin |
|
2017 |
19 |
6 |
p. 1842-1854 |
artikel |
25 |
Quantification of the Pharmacodynamic Interaction of Morphine and Gabapentin Using a Response Surface Approach
|
Papathanasiou, Theodoros |
|
2017 |
19 |
6 |
p. 1804-1813 |
artikel |
26 |
Recommendations for Selection and Characterization of Protein Biomarker Assay Calibrator Material
|
Cowan, Kyra J. |
|
2017 |
19 |
6 |
p. 1550-1563 |
artikel |
27 |
Recommendations for the Assessment and Management of Pre-existing Drug-Reactive Antibodies During Biotherapeutic Development
|
Xue, Li |
|
2017 |
19 |
6 |
p. 1576-1586 |
artikel |
28 |
Role of In Vitro Release Methods in Liposomal Formulation Development: Challenges and Regulatory Perspective
|
Solomon, Deepak |
|
2017 |
19 |
6 |
p. 1669-1681 |
artikel |
29 |
siRNA-Mediated RNA Interference in Precision-Cut Tissue Slices Prepared from Mouse Lung and Kidney
|
Ruigrok, Mitchel J. R. |
|
2017 |
19 |
6 |
p. 1855-1863 |
artikel |
30 |
Submicron Matrices Embedded in a Polymeric Caplet for Extended Intravaginal Delivery of Zidovudine
|
Mashingaidze, Felix |
|
2017 |
19 |
6 |
p. 1745-1759 |
artikel |